Nuclear medicine is a specialized medical field involving the use of minuscule amounts of radioisotopes (RI) in the form of RI-labeled pharmaceutical products for diagnostic procedures or RI-loaded medical devices for disease treatment. At Nihon Medi-Physics, we are engaged in research, development, production, and supply of products utilizing RI’s unique features in both diagnostic and therapeutic applications. Recently, we have expanded our business capabilities to contract businesses, leveraging our expertise to support efficient research and development activities of pharmaceutical companies.

Diagnosis (SPECT / PET radiopharmaceuticals)

Our core business: radiopharmaceuticals for diagnostic nuclear medicine, consists of two categories. One is for SPECT scans, where we have been market leaders for many years. The other is for PET scan—we achieved launching the delivery for the first time in Japan. Nuclear medicine scans using these radiopharmaceuticals can visualize various functions of the human body, contributing to early detection and therapy of cancer, stroke, heart diseases, etc.

Therapeutic field

We distribute medical devices and therapeutic agents created utilizing technologies related to radiation. We introduced the radioactive seed in Japan, which is a tiny capsule loaded with radioisotope, for brachytherapy—a therapeutic procedure to implant radioactive seeds inside the patient’s body for prostate cancer treatment. As a contribution to preparation measures for radiation-related disasters, we distribute the antidotes to eliminate internal contamination by radioactive cesium and trans-uranium elements.